Dosage unit formulations of autologous dermal fibroblasts

• 收藏
• 分享

专利权人:

Inc.;Fibrocell Technologies

发明人:

Maslowski, John

申请号：

AU2011248067

公开号：

AU2011248067B2

申请日:

2011.05.05

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

Dosage units consist of an autologous cell therapy product composed of fibroblasts grown for each individual to be treated. The suspension of autologous fibroblasts, grown from a biopsy of each individual's own skin using current good manufacturing practices (CGMP), and standard tissue culture procedures, is supplied in vials containing cryopreserved fibroblasts or precursors thereof, having a purity of at least 98% fibroblasts and a viability of at least 85%, for administration of from one to six mL, preferably two mL, of cells at a concentration of from 1.0-2.0 x 10

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/